Clinical trials
Phase 1/2 Brain Neoplasms trials in Spain
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
12 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2004 | 1 |
| 2010 | 1 |
| 2013 | 1 |
| 2014 | 2 |
| 2016 | 2 |
| 2020 | 3 |
| 2022 | 1 |
| 2023 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 4 |
| Active, not recruiting | 3 |
| Terminated | 3 |
| Recruiting | 2 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Novartis Pharmaceuticals | 3 |
| Hoffmann-La Roche | 2 |
| AstraZeneca | 1 |
| Eli Lilly and Company | 1 |
| Genzyme, a Sanofi Company | 1 |
| Institut de Recherches Internationales Servier | 1 |
| Memorial Sloan Kettering Cancer Center | 1 |
| Proximagen, LLC | 1 |
| Stemline Therapeutics, Inc. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Brain Neoplasms | 12 |
| Glioblastoma | 4 |
| Breast Neoplasms | 3 |
| Central Nervous System Neoplasms | 3 |
| Neuroblastoma | 3 |
| Glioma | 2 |
| Gliosarcoma | 2 |
| Medulloblastoma | 2 |
| Neoplasms | 2 |
| Recurrence | 2 |
Trials
Showing 1 to 12 of 12. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.